07:45 AM EDT, 09/16/2025 (MT Newswires) -- Immuneering Corp. ( IMRX ) said Tuesday it has appointed Thomas Schall as its chair.
Schall has been on Immuneering's ( IMRX ) board since March 2024 and will support late-stage development and commercialization efforts, the company said.
Immuneering's ( IMRX ) shares were up over 3% in recent Tuesday premarket activity.